Vaishali Pharma Schedules Board Meeting for Q2 and H1 FY27 Results Approval
Vaishali Pharma Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Vaishali Pharma Schedules Board Meeting for Q2 and H1 FY27 Results Approval Vaishali Pharma Ltd. has scheduled a meeting of its Board of Directors on 14th Nov'26. The board will consider and approve the un-audited financial results along with the Limited Review Report for the second quarter and half year ended 30th Sep'26, pursuant to Regulation 33 of SEBI LODR Regulations, 2015, alongside other general business matters.
Original exchange filing (PDF)
More announcements from Vaishali Pharma Ltd
- Vaishali Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 路 15 Nov 2026
- Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Appointment of Mr. Rohil Sanjay Desai and Mr. Ketur Kishor Shah as Non- Executive Independent Director of the company w.e.f. November 05, 2026. 路 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. 路 06 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve Other business/Increase in authorised capital/Fund raising. 路 03 Nov 2026
- To consider Fund Raising and other business matters 路 03 Nov 2026
- Vaishali Pharma Limited has informed the Exchange about General Updates 路 17 Oct 2026
